Quick Answer
Aurinia Pharmaceuticals Inc. reported Shares Outstanding of 132.32 million shares for fiscal year 2025.
Aurinia Pharmaceuticals Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 132.32M | -6.1% |
| 2024 | 140.88M | -2.1% |
| 2023 | 143.83M | +1.1% |
| 2022 | 142.27M | +0.5% |
| 2021 | 141.60M | +11.8% |
| 2020 | 126.70M | +13.3% |
| 2019 | 111.80M | +30.8% |
| 2018 | 85.50M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 131.84M | -7.9% | -0.6% |
| June 30, 2025 | 132.67M | -7.2% | -3.7% |
| March 31, 2025 | 137.75M | -4.1% | -2.2% |
| December 31, 2024 | 140.88M | -2.1% | -1.6% |
| September 30, 2024 | 143.11M | -0.3% | +0.1% |
| June 30, 2024 | 142.98M | -0.3% | -0.5% |
| March 31, 2024 | 143.69M | +0.5% | -0.1% |
| December 31, 2023 | 143.83M | +1.1% | +0.2% |
- Aurinia Pharmaceuticals Inc. showed a decrease of -6.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2018–2025 period, Aurinia Pharmaceuticals Inc.’s shares outstanding has grown by 54.8% (from 85.50 million shares to 132.32 million shares).
- The most recent figure is from Aurinia Pharmaceuticals Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: